A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes
Data Supplement
Files in this Data Supplement:
This Article
-
doi: 10.2337/dc05-1365 Diabetes Care June 2006 vol. 29 no. 6 1269-1274
- AbstractFree
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
From the Cover
- Driving mishaps among individuals with type 1 diabetes: a prospective study
- Projecting the future diabetes population size and related costs for the U.S.
- Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus
- Are metabolically normal but obese individuals at lower risk for all-cause mortality?
